Kimia Biosciences Ltd Financials
Company Logo

Kimia Biosciences Ltd Financial Statement

Kimia Biosciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue24.43
Operating Expense21.06
Net Profit0.60
Net Profit Margin2.46
Earning Per Share0.13
EBIDTA3.29
Effective Tax RateTBA

Kimia Biosciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual118.92
Operating Expenses Annual98.67
Operating Profit Annual21.57
Interest Annual4.56
Depreciation3.36
Net Profit Annual9.61
Tax Annual4.02

Kimia Biosciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.15
Cash Flow from Operations21.31
Cash Flow from Investing-4.70
Cash Flow from Financing-16.55
Cash Flow at the End0.21

Kimia Biosciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)18.14
PBIT Margin (%)15.30
PBT Margin (%)11.94
Net PROFIT Margin (%)8.08
Return On Networth / Equity (%)172.53
Return On Networth /Employed (%)34.57
Return On Assets (%)18.42
Total Debt / Equity (X)7.46
Asset Turnover Ratio (%)2.28

Kimia Biosciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual33.28
Total Current Assets Annual75.29
Non Current Assets Annual35.92
Total Shareholders Funds Annual9.97
Total Assets Annual111.21

Kimia Biosciences Ltd Earning Calls

No Data Availabe

FAQS on Kimia Biosciences Ltd Financials

As of Oct 2, 2025, Kimia Biosciences Ltd has a market capitalization of 201.13 Cr. Value Research classifies it as a Small-Cap company.

Yes, Kimia Biosciences Ltd is not with a debt-to-equity ratio of 3.31.

In FY 2024 , Kimia Biosciences Ltd recorded a total revenue of approximately 118.92 Cr marking a significant milestone in the company's financial performance.

Kimia Biosciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and -0.0% annually, respectively..

Kimia Biosciences Ltd's current PE ratio is 20.93.

Kimia Biosciences Ltd's ROCE averaged 6.6% from the FY ending March 2023 to 2025, with a median of -4.2%. It peaked at 36.3% in March 2025, reflecting strong capital efficiency over the period..

Kimia Biosciences Ltd's latest EBIT is Rs. 18.19 Cr, surpassing the average EBIT of Rs. 2.64 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions